Reports for ACTAVIS PHARMA COMPANY
Company Name
ACTAVIS PHARMA COMPANY
Totals |
||
Shortage reports |
13 |
|
| Actual shortage: | 7 (54%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 0 (0%) | |
| Resolved: | 6 (46%) | |
Discontinuation Reports |
56 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 56 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
58 (84%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT PREGABALIN | 75MG | CAPSULE | Discontinued | 2018-10-22 | 2018-10-22 | 65236 |
| ACT PREGABALIN | 225MG | CAPSULE | Discontinued | 2018-10-22 | 2018-10-22 | 65239 |
| ACT PREGABALIN | 50MG | CAPSULE | Discontinued | 2018-10-22 | 2018-10-22 | 65242 |
| ACT PREGABALIN | 25MG | CAPSULE | Discontinued | 2018-10-22 | 2018-10-22 | 65245 |
| ACT PREGABALIN | 75MG | CAPSULE | Discontinued | 2018-10-22 | 2018-10-22 | 65248 |
| ACT PREGABALIN | 150MG | CAPSULE | Discontinued | 2018-10-22 | 2018-10-22 | 65251 |
| ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65050 | ||
| ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65052 | ||
| ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65068 | ||
| ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65071 | ||
| ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65074 | ||
| ACT LISINOPRIL | Discontinued | 2018-10-22 | 2018-10-22 | 65121 | ||
| ACT LISINOPRIL | Discontinued | 2018-10-22 | 2018-10-22 | 65124 | ||
| ACT LISINOPRIL | Discontinued | 2018-10-22 | 2018-10-22 | 65127 | ||
| RECLIPSEN 21 | Discontinued | 2018-11-20 | 2018-11-20 | 67254 | ||
| RECLIPSEN 28 | Discontinued | 2018-11-20 | 2018-11-20 | 67257 |